Roche’s cardiometabolic chief warns against weight loss ‘obsession’ with GLP-1snews2025-01-16T21:00:18+00:00January 16th, 2025|Endpoints News|
Teva says it has a ‘unique position’ in latest IRA challengenews2025-01-16T20:20:48+00:00January 16th, 2025|Endpoints News|
HHS blasts Boehringer’s drug price case, reveals new details on Jardiance talksnews2025-01-16T20:09:36+00:00January 16th, 2025|Endpoints News|
EMA in 2024 recommended highest number of drug approvals in 15 yearsnews2025-01-16T17:49:07+00:00January 16th, 2025|Endpoints News|
Novartis enters fight against HHS for denying its 340B rebate modelnews2025-01-16T16:20:31+00:00January 16th, 2025|Endpoints News|
Eli Lilly’s Omvoh earns FDA approval for Crohn’s diseasenews2025-01-15T22:15:14+00:00January 15th, 2025|Endpoints News|
DEA issues proposed rule to permanently expand online prescribing of controlled substancesnews2025-01-15T21:47:54+00:00January 15th, 2025|Endpoints News|
Vertex’s fertility support bid is ‘self-serving,’ HHS saysnews2025-01-15T20:21:52+00:00January 15th, 2025|Endpoints News|
Drugmakers again tout limits of IRA impactnews2025-01-15T16:18:12+00:00January 15th, 2025|Endpoints News|
#JPM25: Day 3 at the JP Morgan Healthcare Conferencenews2025-01-15T12:20:57+00:00January 15th, 2025|Endpoints News|
